| |
|
<< Prev
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Next >> |
|
|
| |
Conference on Pharmaceutical Quality Systems
[85 Words]
[ Price : $7.95]
|
| Federal Register Notice: FDA and the International Society of Pharmaceutical Engineering will co-sponsor a conference on a culture of quality in the pharmaceutical quality system. |
|
05/07/2013
|
| |
|
| |
Latest FDA Warning Letters
[731 Words]
[ Price : $7.95]
|
| In its latest batch of Warning Letters, FDA cites Coral Rock Man, Glottal Enterprises, Hillestad Pharmaceuticals USA, Medicamat, Musculoskeletal Transplant Foundation, and Natural Medicine AssociatesSunset Natural Products. |
|
05/07/2013
|
| |
|
|
|
| |
Judge to Rule on FDA Plan B Stay Request This Week
[374 Words]
[ Price : $7.95]
|
| New York federal judge Edward Korman says he will rule by the end of the week on FDA’s request to stay his order last month that the agency lift age restrictions on all levonorgestrel-based emergency contraceptives. |
|
05/07/2013
|
| |
|
|
|
|
|
|
|
| |
FDA Grants AbbVie Breakthrough Therapy Designation
[238 Words]
[ Price : $7.95]
|
| FDA grants AbbVie a breakthrough therapy designation for its investigational direct-acting antiviral combination with and without ribavirin for treating genotype 1 hepatitis C virus infection. |
|
05/06/2013
|
| |
|
| |
FDA Safety Alert on Anti-seizure Drugs and Pregnancy Use
[274 Words]
[ Price : $7.95]
|
| A new FDA drug safety alert says the anti-seizure drug valproate sodium and related products, valproic acid and divalproex sodium, are contraindicated and should not be taken by pregnant women for preventing migraine headaches. |
|
05/06/2013
|
| |
|
| |
|
<< Prev
3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Next >> |
| |